Page last updated: 2024-08-24

rutecarpine and Acute Kidney Injury

rutecarpine has been researched along with Acute Kidney Injury in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Cai, YT; Dong, YH; Jiang, L; Jin, J; Li, J; Li, Z; Liu, MM; Liu, XQ; Ma, TT; Meng, XM; Wang, JN; Wen, JG; Wu, MF; Wu, YG	1

Other Studies

1 other study(ies) available for rutecarpine and Acute Kidney Injury

Article	Year
Rutaecarpine derivative Cpd-6c alleviates acute kidney injury by targeting PDE4B, a key enzyme mediating inflammation in cisplatin nephropathy. Biochemical pharmacology, 2020, Volume: 180 Topics: Acute Kidney Injury; Animals; Anti-Inflammatory Agents; Apoptosis; Cell Line; Cisplatin; Cyclic Nucleotide Phosphodiesterases, Type 4; Disease Models, Animal; Epithelial Cells; Humans; Indole Alkaloids; Kidney Tubules; Male; Mice, Inbred C57BL; Molecular Docking Simulation; Oxidative Stress; Protein Binding; Quinazolines	2020

Article

Year

Rutaecarpine derivative Cpd-6c alleviates acute kidney injury by targeting PDE4B, a key enzyme mediating inflammation in cisplatin nephropathy.

Biochemical pharmacology, 2020, Volume: 180

Topics: Acute Kidney Injury; Animals; Anti-Inflammatory Agents; Apoptosis; Cell Line; Cisplatin; Cyclic Nucleotide Phosphodiesterases, Type 4; Disease Models, Animal; Epithelial Cells; Humans; Indole Alkaloids; Kidney Tubules; Male; Mice, Inbred C57BL; Molecular Docking Simulation; Oxidative Stress; Protein Binding; Quinazolines

2020